Stock Analiz

IBEX Ltd IBEX

EDP Services · IPO 2020 · data as of November 13, 2026

$56.92Market cap $759M
Open the interactive analysis →

IBEX Ltd (IBEX) is a technology company listed in the US with a market value of about $759M. In the twelve months to September 30, 2026 it had revenue of $668M and net income of $49M, a net margin of 7.3%.

Its overall Stock Analiz score is 3.4 out of 5 (good). The strongest part is financial health (5/5); the weakest is shareholder returns (2/5).

Key numbers: a P/E of 17.2, a price to free cash flow of 23.5, 5-year revenue growth of 8% a year, a 5-year average ROIC of 15%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 29% below the current price.

About IBEX

IBEX is listed in the US and classified in edp services, IPO year 2020. Revenue went from $342M in 2018 to $644M in 2026, growth of about 8.2% a year. It was profitable in 8 of the last 9 years in our data.

Score: 3.4 / 5

Value3/5
Future growth3/5
Track record4/5
Financial health5/5
Shareholder returns2/5

Checks passed

  • P/E below 25
  • P/E below the industry median
  • PEG below 1.5
  • Revenue growth above 10% last year
  • Profit margin improving
  • 3-year free cash flow growth above 10% a year
  • 5-year EPS growth above 10% a year
  • 5-year average ROIC above 12%

Checks not passed

  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • 3-year revenue growth above 10% a year
  • Strong R&D investment or growth above 20%
  • 5-year revenue growth above 8% a year
  • Pays a dividend
  • Share count down over 3 years (buybacks)
  • Dividend 3 years in a row

Valuation

P/E (TTM)17.2
Forward P/E13.6
P/FCF23.5
P/S1.1
P/B4.2
EV/EBITDA9.8
PEG0.50
Dividend yield0.00%
FCF yield4.3%
Shareholder yield1.9%
Intrinsic value vs. price−29%

Growth and quality

Revenue growth (1 yr)15.4%
Revenue growth (5 yrs, per year)7.8%
EPS growth (5 yrs, per year)34.5%
FCF growth (3 yrs, per year)10.8%
Net margin (5-yr avg.)6.2%
ROIC (5-yr avg.)14.7%
Profitable years (of last 10)8
Years paying a dividend4

Financials, last 9 years

Fiscal yearTTM202620252024202320222021202020192018
Revenue$668M$644M$558M$509M$523M$493M$443M$405M$368M$342M
Net income$49M$46M$37M$34M$32M$21M$13M$8M$11M-$16M
Free cash flow$32M$31M$27M$27M$23M$14M-$5M$47M-$3M-$11M
EPS (diluted)$3.30$3.47$2.76$2.52$2.37$1.61$0.98$0.58$0.82$-1.19
Net margin7.3%7.2%6.6%6.6%6.0%4.3%2.9%1.9%3.0%-4.6%
ROIC—20.2%18.3%13.9%13.9%7.4%11.9%30.1%9.6%-68.2%

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

What analysts expect

The average 12-month price target from 2 analysts is $46.50, 18% below the current price; targets range from $45.00 to $48.00; the consensus rating is “Hold”; expected EPS is $4.08 for the fiscal year ending June 30, 2027.

Frequently asked questions

What is IBEX’s P/E ratio?

About 17.2, based on the last twelve months of diluted earnings per share (forward P/E about 13.6).

Is IBEX stock undervalued?

Our DCF model with moderate assumptions puts its intrinsic value about 29% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.

Does IBEX pay a dividend?

Not currently.

Is IBEX a good stock to buy?

We do not give buy or sell advice. IBEX scores 3.4 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.